联合磁共振成像、增强 CT 和 18F-FDG PET/CT 在诊断卵巢癌术后复发和转移中的价值。

IF 2.8 3区 医学 Q2 ONCOLOGY Clinical & Translational Oncology Pub Date : 2024-12-01 Epub Date: 2024-05-23 DOI:10.1007/s12094-024-03499-0
Yong Hong, Jianfeng Peng, Yanni Zeng, Xuewen Deng, Wanjun Xu, Juanting Wang
{"title":"联合磁共振成像、增强 CT 和 18F-FDG PET/CT 在诊断卵巢癌术后复发和转移中的价值。","authors":"Yong Hong, Jianfeng Peng, Yanni Zeng, Xuewen Deng, Wanjun Xu, Juanting Wang","doi":"10.1007/s12094-024-03499-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this article was to investigate the value of combined MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.</p><p><strong>Methods: </strong>Ninety-five ovarian cancer patients were selected as the study subjects, all of them underwent surgical treatment, and MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT were performed on all of them in the postoperative follow-up, and the pathological results after the second operation were used as the diagnostic \"gold standard\". The diagnostic value (sensitivity, specificity, accuracy, negative predictive value and positive predictive value) of the three examination methods alone or in combination for the diagnosis of postoperative recurrence and metastasis of ovarian cancer was compared, and the detection rate was calculated when the lesion was the unit of study, so as to compare the efficacy of the three methods in the diagnosis of postoperative recurrent metastatic lesions of ovarian cancer.</p><p><strong>Results: </strong>The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of the combined group were higher than those of MRI and enhanced CT for recurrence and metastasis of ovarian cancer after surgery, and the specificity, accuracy and positive predictive value of the combined group were higher than those of the <sup>18</sup>F-FDG PET/CT group, and those of the <sup>18</sup>F-FDG PET/CT group were higher than those of the enhanced CT group (all P < 0.05). When the postoperative recurrent metastatic lesions of ovarian cancer were used as the study unit, the detection rate of lesions in the combined group was higher than that of the three examinations detected individually, and the detection rate of lesions in <sup>18</sup>F-FDG PET/CT was higher than that of enhanced CT and MRI (P < 0.05).</p><p><strong>Conclusion: </strong>The combination of MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT can accurately diagnose recurrence and metastasis of ovarian cancer after surgery, detect recurrent metastatic lesions as early as possible, and improve patients' prognosis.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"3013-3019"},"PeriodicalIF":2.8000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The value of combined MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.\",\"authors\":\"Yong Hong, Jianfeng Peng, Yanni Zeng, Xuewen Deng, Wanjun Xu, Juanting Wang\",\"doi\":\"10.1007/s12094-024-03499-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The purpose of this article was to investigate the value of combined MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.</p><p><strong>Methods: </strong>Ninety-five ovarian cancer patients were selected as the study subjects, all of them underwent surgical treatment, and MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT were performed on all of them in the postoperative follow-up, and the pathological results after the second operation were used as the diagnostic \\\"gold standard\\\". The diagnostic value (sensitivity, specificity, accuracy, negative predictive value and positive predictive value) of the three examination methods alone or in combination for the diagnosis of postoperative recurrence and metastasis of ovarian cancer was compared, and the detection rate was calculated when the lesion was the unit of study, so as to compare the efficacy of the three methods in the diagnosis of postoperative recurrent metastatic lesions of ovarian cancer.</p><p><strong>Results: </strong>The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of the combined group were higher than those of MRI and enhanced CT for recurrence and metastasis of ovarian cancer after surgery, and the specificity, accuracy and positive predictive value of the combined group were higher than those of the <sup>18</sup>F-FDG PET/CT group, and those of the <sup>18</sup>F-FDG PET/CT group were higher than those of the enhanced CT group (all P < 0.05). When the postoperative recurrent metastatic lesions of ovarian cancer were used as the study unit, the detection rate of lesions in the combined group was higher than that of the three examinations detected individually, and the detection rate of lesions in <sup>18</sup>F-FDG PET/CT was higher than that of enhanced CT and MRI (P < 0.05).</p><p><strong>Conclusion: </strong>The combination of MRI, enhanced CT and <sup>18</sup>F-FDG PET/CT can accurately diagnose recurrence and metastasis of ovarian cancer after surgery, detect recurrent metastatic lesions as early as possible, and improve patients' prognosis.</p>\",\"PeriodicalId\":50685,\"journal\":{\"name\":\"Clinical & Translational Oncology\",\"volume\":\" \",\"pages\":\"3013-3019\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12094-024-03499-0\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-024-03499-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的本文旨在探讨MRI、增强CT和18F-FDG PET/CT联合应用在卵巢癌术后复发和转移诊断中的价值:方法:选取95例卵巢癌患者作为研究对象,所有患者均接受了手术治疗,术后随访时均进行了MRI、增强CT和18F-FDG PET/CT检查,并将第二次手术后的病理结果作为诊断 "金标准"。比较三种检查方法单独或联合诊断卵巢癌术后复发和转移的诊断价值(敏感性、特异性、准确性、阴性预测值和阳性预测值),以病灶为研究单位计算检出率,从而比较三种方法在卵巢癌术后复发转移病灶诊断中的疗效:联合组对卵巢癌术后复发和转移的敏感性、特异性、准确性、阳性预测值和阴性预测值均高于MRI和增强CT,联合组的特异性、准确性和阳性预测值均高于18F-FDG PET/CT组,18F-FDG PET/CT组的特异性、准确性和阳性预测值均高于增强CT组(均P 18F-FDG PET/CT的特异性、准确性和阳性预测值均高于增强CT和MRI(P 结论:MRI、增强CT和联合组对卵巢癌术后复发和转移的敏感性、特异性、准确性、阳性预测值和阴性预测值均高于MRI和增强CT:MRI、增强CT和18F-FDG PET/CT联合应用可准确诊断卵巢癌术后复发和转移,尽早发现复发转移病灶,改善患者预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The value of combined MRI, enhanced CT and 18F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.

Objective: The purpose of this article was to investigate the value of combined MRI, enhanced CT and 18F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.

Methods: Ninety-five ovarian cancer patients were selected as the study subjects, all of them underwent surgical treatment, and MRI, enhanced CT and 18F-FDG PET/CT were performed on all of them in the postoperative follow-up, and the pathological results after the second operation were used as the diagnostic "gold standard". The diagnostic value (sensitivity, specificity, accuracy, negative predictive value and positive predictive value) of the three examination methods alone or in combination for the diagnosis of postoperative recurrence and metastasis of ovarian cancer was compared, and the detection rate was calculated when the lesion was the unit of study, so as to compare the efficacy of the three methods in the diagnosis of postoperative recurrent metastatic lesions of ovarian cancer.

Results: The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of the combined group were higher than those of MRI and enhanced CT for recurrence and metastasis of ovarian cancer after surgery, and the specificity, accuracy and positive predictive value of the combined group were higher than those of the 18F-FDG PET/CT group, and those of the 18F-FDG PET/CT group were higher than those of the enhanced CT group (all P < 0.05). When the postoperative recurrent metastatic lesions of ovarian cancer were used as the study unit, the detection rate of lesions in the combined group was higher than that of the three examinations detected individually, and the detection rate of lesions in 18F-FDG PET/CT was higher than that of enhanced CT and MRI (P < 0.05).

Conclusion: The combination of MRI, enhanced CT and 18F-FDG PET/CT can accurately diagnose recurrence and metastasis of ovarian cancer after surgery, detect recurrent metastatic lesions as early as possible, and improve patients' prognosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
期刊最新文献
Correction: Multi‑index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non‑small cell lung cancer. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma. Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis. ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis. The value of combined MRI, enhanced CT and 18F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1